EUR > Medicine & Health > Erasmus MC > View Doctoral Thesis
http://hdl.handle.net/1765/1377
isbn: 978-907224-594-6
series: Erasmus MC;Diss. EUR 2000:058

From Evidence to Decision Support in Cancer Screening; Application of Miscan Models


Doctoral Thesis
Related Files
asset icon
(Boer_thesis.pdf, 0.9MB)
asset icon
(04.pdf, 0.2MB)
asset icon
(05.pdf, 0.2MB)
asset icon
(02.pdf, 0.1MB)
asset icon
(08.pdf, 0.1MB)
asset icon
(12.pdf, 0.1MB)
asset icon
(03.pdf, 0.1MB)
asset icon
(10.pdf, 0.1MB)
asset icon
(07.pdf, 0.1MB)
asset icon
(22.pdf, 0.1MB)
asset icon
(06.pdf, 0.1MB)
asset icon
(09.pdf, 0.1MB)
asset icon
(13.pdf, 0.1MB)
asset icon
(01.pdf, 0.0MB)
asset icon
(21.pdf, 0.0MB)
asset icon
(11.pdf, 0.0MB)
asset icon
(20.pdf, 0.0MB)
asset icon
(001.pdf, 0.0MB)
asset icon
(003.pdf, 0.0MB)
asset icon
(32.pdf, 0.0MB)
asset icon
(00.pdf, 0.0MB)

Making decisions to introduce or change cancer screening that are based on observed evidence is not straight forward. Even if there is evidence available from randomised controlled trials that clearly proves a reduction in mortality from the cancer in question, there are still several issues to be resolved before an evidence based decision can be made on the introduction or change of a screening programme. One of the factors is cost effectiveness.


Supervisor (promotor):

Prof. Dr. Maas, P.J. van der

The author wishes to thank:

Maas, Prof. Dr. P.J. van der (promotor)
Ministerie van Volksgezondheid


Keywords


Automatically Extracted Terms
  • vfuhhqlqj
  • fdqfhu
  • euhdvw
  • vxuylydo
  • zrphq
  • prgho
  • zklfk
  • pruwdolw
  • fdvhv
  • hiihfwv
  • ghdwk
  • wuldov
  • surjudpph
  • iluvw
  • ehwzhhq
  • srsxodwlrq
  • glvhdvh
  • fdqfhuv
  • glvwulexwlrq
  • wuldo


Bookmark with: